| Financial Year |
March 31 2023 |
| Monetary Funds |
9,184,634,851.28 |
| Held-for-trading Financial Assets |
101,533,398.14 |
| Notes Receivable |
4,522,340,441.68 |
| Accounts Receivable |
7,859,750,409.35 |
| Advances to Suppliers |
124,636,559.86 |
| Other Receivables |
51,808,407.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,758,258,290.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
230,488,254.32 |
| Total Current Assets |
26,844,091,945.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
269,468,818.50 |
| Investment Properties |
3,059,022.15 |
| Fixed Assetes |
3,346,540,612.44 |
| Under-construction Projects |
1,280,762,044.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
600,669,365.75 |
| R&D expenses |
-- |
| Goodwill |
69,121,895.47 |
| Long-Term Deferred and Prepaid Expenses |
8,578,585.57 |
| Deferred Income Tax Assets |
192,712,505.24 |
| Other Non-Current Assets |
47,074,369.31 |
| Sub-Total of Non-Current Assets |
5,935,120,847.15 |
| Total Assets |
32,779,212,792.80 |
| Short-Term Loans |
646,206,305.08 |
| Trading Financial liabilities |
101,399,062.61 |
| Notes Payable |
3,565,173,789.77 |
| Accounts Payable |
4,141,756,293.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
513,642,756.97 |
| Taxes Payable |
97,671,252.93 |
| Interest Payable |
-- |
| Dividend Payable |
113,280,224.47 |
| Other payables |
1,725,387,888.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
743,731,373.57 |
| Other Current Liabilities |
148,699,005.33 |
| Sub-Total of Current Liabilities |
12,191,947,082.72 |
| Long-term Loans |
60,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-61,286,943.83 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
144,330,450.44 |
| Other Non-Current Liabilities |
218,547,989.71 |
| Sub-Total of Non-Current Liabilities |
674,368,899.20 |
| Total Liabilities |
12,866,315,981.92 |
| Paid-In Capital(Or Share Stock) |
1,630,804,888.00 |
| Capital Surplus |
7,626,261,486.40 |
| Surplus Reserve |
2,063,265,649.90 |
| LESS:Treasury Stock |
1,545,886,454.42 |
| Undistributed Profits |
8,945,334,689.89 |
| Minority Stockholder's Interest |
1,145,230,154.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,767,666,656.50 |
| Owner's Equity（Stockholder's Equity） |
19,912,896,810.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,779,212,792.80 |
